Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Antonio R, Cabral"'
Autor:
Ummugulsum Gazel, Gizem Ayan, Dilek Solmaz, Nancy Maltez, Tim Ramsay, Antonio R. Cabral, Servet Akar, Sibel Zehra Aydin
Publikováno v:
European Journal of Rheumatology, Vol 10, Iss 3, Pp 118-119 (2023)
Externí odkaz:
https://doaj.org/article/733632c4c5cf4809a20da9b476a5f608
Autor:
Paola Bermúdez-Bermejo, Gabriela Hernández-Molina, Diego F. Hernández-Ramírez, Elizabeth Olivares-Martínez, Antonio R. Cabral, Victor Zamora-Legoff, Carlos A. Núñez-Álvarez
Publikováno v:
Thrombosis Research. 174:141-147
Objective The clinical significance of anti-phosphatidylserine/prothrombin (aPS/PT) in antiphospholipid syndrome (APS) is still controversial. We assessed the prevalence of aPS/PT antibodies, their association with other anti-phospholipid antibodies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f2692e7a5e84dec7de754b3f1c4dadfc
https://doi.org/10.1016/j.thromres.2018.12.023
https://doi.org/10.1016/j.thromres.2018.12.023
Publikováno v:
International Journal of Rheumatic Diseases. 20:755-759
AIM To evaluate health-related quality of life (HRQoL) in primary antiphospholipid syndrome (PAPS) and correlate it with a crude estimate of accrual organ damage, comorbidity (diabetes mellitus, hypertension and dyslipidemia) and treatment (oral anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15932b8d37921da0c04659ed1671e411
https://doi.org/10.1111/1756-185x.13045
https://doi.org/10.1111/1756-185x.13045
Autor:
Virginia Pascual Ramos, Diego F. Hernández-Ramírez, Alicia Ortega, Antonio R. Cabral, Javier Cabiedes, Araceli Martı́nez-Castillo, Carlos A. Núñez-Álvarez
Publikováno v:
Human Immunology. 78:146-152
Homozygote genotype V 247 of the β 2 -glycoprotein-I (β 2 GP-I) gene has been associated with anti-β 2 GP-I and thrombosis in patients with primary anti-phospholipid syndrome APS (PAPS). However, the cellular immune response to β 2 GP-I 247 has b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::53d5a9dc549e92e3e3342646028b25fc
https://doi.org/10.1016/j.humimm.2016.12.008
https://doi.org/10.1016/j.humimm.2016.12.008
Autor:
Andrea Sierra-Sepúlveda, Diego E. Sordo-Lima, Antonio R. Cabral-Castaneda, Sergio A. Benavides-Suárez, Alexia Esquinca-González, Adrián E. Caballero-Islas, Tatiana S. Rodriguez-Reyna
Publikováno v:
BioMed Research International, Vol 2019 (2019)
BioMed Research International
BioMed Research International
Systemic sclerosis (SSc) is a complex rheumatologic autoimmune disease in which inflammation, fibrosis, and vasculopathy share several pathogenic pathways that lead to skin and internal organ damage. Recent findings regarding the participation and in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::266f3473add4603594f370d127348e0b
https://doaj.org/article/f78cf7ece6194d0ba3954bc8c4cd9b61
https://doaj.org/article/f78cf7ece6194d0ba3954bc8c4cd9b61
Autor:
W. Joseph McCune, Diego F. Hernández-Ramírez, Srilakshmi Yalavarthi, Nayef M. Kazzaz, Carlos A. Núñez-Álvarez, Paula L. Bockenstedt, Alex A. Gandhi, Robert C. Grenn, Jason S. Knight, Antonio R. Cabral
Publikováno v:
Annals of the Rheumatic Diseases. 76:450-457
ObjectivesPatients with antiphospholipid syndrome (APS) are at risk for subclinical endothelial injury, as well as accelerated atherosclerosis. In the related disease systemic lupus erythematosus, there is a well-established defect in circulating end
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ec70475b61eb60d937f98a714649d6c
https://doi.org/10.1136/annrheumdis-2016-209442
https://doi.org/10.1136/annrheumdis-2016-209442
Autor:
Carlos A, Núñez-Álvarez, Gabriela, Hernández-Molina, Paola, Bermúdez-Bermejo, Victor, Zamora-Legoff, Diego F, Hernández-Ramírez, Elizabeth, Olivares-Martínez, Antonio R, Cabral
Publikováno v:
Thrombosis research. 174
The clinical significance of anti-phosphatidylserine/prothrombin (aPS/PT) in antiphospholipid syndrome (APS) is still controversial. We assessed the prevalence of aPS/PT antibodies, their association with other anti-phospholipid antibodies (aPL) and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8c453b7eb28a0886fc8e86976c554d91
https://pubmed.ncbi.nlm.nih.gov/30612005
https://pubmed.ncbi.nlm.nih.gov/30612005
Autor:
Paula L. Bockenstedt, Travis J. Gould, Diego F. Hernández-Ramírez, Srilakshmi Yalavarthi, Antonio R. Cabral, Carlos A. Núñez-Álvarez, Patricia C. Liaw, Alexandra E. Morris, Ashish N. Rao, Levi F. Mazza, Jason S. Knight
Publikováno v:
Arthritis & Rheumatology. 67:2990-3003
Objective Antiphospholipid antibodies (aPL), especially those targeting β2-glycoprotein I (β2GPI), are well known to activate endothelial cells, monocytes, and platelets, with prothrombotic implications. In contrast, the interaction of aPL with neu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::09b347ed43f2dea8eb9b723dbb4c9e6a
https://doi.org/10.1002/art.39247
https://doi.org/10.1002/art.39247
Autor:
Diego F. Hernández-Ramírez, Elizabeth Olivares-Martínez, Antonio R. Cabral, Luis Llorente, Carlos A. Núñez-Álvarez
Publikováno v:
Clinical Rheumatology. 35:55-61
The objective of this study was to determine the relationship between citrullinated proteins in synovial tissue with peripheral anti-citrullinated peptides autoantibodies (ACPA) and peptidylarginine deiminase (PADI) PADI2, PADI3, and PADI4 messenger
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcfc60e9152c80bb13669b3a08760344
https://doi.org/10.1007/s10067-015-3047-2
https://doi.org/10.1007/s10067-015-3047-2
Autor:
ANTONIO R. CABRAL
Publikováno v:
Salud Pública de México, Vol 39, Iss 5, Pp 493-494 (1997)
Externí odkaz:
https://doaj.org/article/70d0a1fba60248889e86954624d55991